NFKB1 and cancer: Previous studies have illustrated that p53 acts as a unique regulator for suppressing NF-κB and aids in preventing its binding to promotor DNA binding sites (Murphy et al., 2011) NF-κB may become overactive in cancer cells because p53 activity is lost (Murphy et al., 2011).